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ABSTRACT
Targeted mutagenesis directed by oligonucleotides
(ONs) is a promising method for manipulating the
genome in higher eukaryotes. In this study, we have
compared gene editing by different ONs on two new
target sequences, the eBFP and the rd1 mutant
photoreceptor bPDE cDNAs, which were integrated
as single copy transgenes at the same genomic site
in 293T cells. Interestingly, antisense ONs were
superior to sense ONs for one target only, showing
thattargetsequencecanbyitselfimpartstrand-biasin
gene editing. The most efficient ONs were short 25 nt
ONs with flanking locked nucleic acids (LNAs), a
chemistry that had only been tested for targeted
nucleotide mutagenesis in yeast, and 25 nt ONs with
phosphorothioate linkages. We showed that LNA-
modified ONs mediate dose-dependent target modi-
fication and analyzed the importance of LNA position
and content. Importantly, when using ONs with flank-
ing LNAs, targeted gene modification was stably
transmitted during cell division, which allowed reli-
able cloning of modified cells, a feature essential
for further applications in functional genomics
and gene therapy. Finally, we showed that ONs with
flanking LNAs aimed at correcting the rd1 stop muta-
tion could promote survival of photoreceptors in
retinas of rd1 mutant mice, suggesting that they are
also active in vivo.
INTRODUCTION
Targeted mutagenesis is a major method of genetics which, in
practice, still remains restricted to the mouse model organism
and a few speciﬁc cell lines in other higher eukaryotes (1).
Furthermore, it relies on homologous recombination between
the targeted gene and large DNA molecules requiring the
construction of complex plasmid, BAC or adeno-associated
viral vectors. Therefore, strategies using simpler vectors for
targeted mutagenesis, such as oligonucleotides (ONs) or small
DNA fragments, constitute attractive alternatives to manip-
ulate the genome for both experimental and therapeutic pur-
poses. ON-mediated targeted mutagenesis has been used to
correct point mutations in cultured cells and in animal models
of human disease (2–4). Several types of ONs have been
shown to be active, including small RNA/DNA ONs,
single-stranded and branched ONs (3–5). Triplex-forming
ONs have also been used to induce sequence-speciﬁc deletions
(6). However, the critical experimental parameters and the
mechanisms involved in these methods are not well known.
Indeed, the high mutagenesis rates originally reported when
using small RNA/DNA ONs could often not be reproduced on
different targets or on identical targets using seemingly ident-
ical experimental conditions (3,7,8). Some authors have sug-
gested that mutagenesis rates could have been overestimated
in some studies because of PCR artifacts (3,9). Differences in
the sequences targeted as well as in the assays used to measure
mutagenesis rates make it difﬁcult to compare the activity of
the vectors described in the various studies.
In this study, we have compared the targeting efﬁciency of
several types of ONs previously shown to mediate targeted
mutagenesis on both episomal and integrated single copy
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a methylene bridge connecting the 20-oxygen of ribose with
the 40-carbon (10), had been previously shown to direct tar-
geted nucleotide modiﬁcation in yeast (11), but their activity
had not been reported in higher eukaryotes so far. Here, we
show that short speciﬁc ONs with ﬂanking LNAs induced the
desired mutation atthe DNA level and, importantly,thatmodi-
ﬁed cell clones could be isolated and grown for each of the
sequences targeted, the eBFP and the rd1 mutant photore-
ceptor cDNAs. As previously shown for phosphorothioate
ONs (C. Andrieu-Soler et al., manuscript submitted), speciﬁc
ONs with ﬂanking LNAs could increase the number of
photoreceptors in vivo in the retina of rd1 mice (12). Taken
together, our results suggest that short ONs with ﬂanking
LNAs can be powerful reagents for targeted mutagenesis in
cultured cells and in animal models of human disease.
MATERIALS AND METHODS
Oligonucleotides
ONs were synthesized and puriﬁed by high-pressure liquid
chromatography by Proligo (Paris, France) with the exception
of the branched-PS-eGFP ON, which was synthesized by
Eurogentech. ONs in distilled water were quantiﬁed by
absorbance at 260 nm.
Plasmids
The pFRT/lacZeo vector contains a FRT site and a LacZ–
Zeocin fusion gene (Invitrogen, Cergy Pontoise, France).
pOG44 vector (Invitrogen) constitutively expresses the Flp
recombinase (13). peBFP and peGFP* were constructed by
inserting eBFP cDNA and eGFP cDNA, respectively, without
the translation initiation codon into BamH1/Xho1 sites of the
pcDNA5/FRT/TO plasmid (Invitrogen). prd1-eGFP* and
pPDE-eGFP* were constructed by inserting a 153 bp fragment
containing bPDE sequence spanning the rd1 mutation or its
wild-type counterpart, respectively, in HindIII/BamH1 sites
of the peGFP* (inserting a shorter fragment of rd1 sequence
in peGFP* or the 153 bp fragment in a peGFP containing
the translation initiation codon led to background green
ﬂuorescence).
Cells cultures and establishment of stable cell lines
All media, fetal bovine serum (FBS) and Penicillin–
Streptomycin were from Gibco BRL. 293T cells were main-
tained in DMEM supplemented with 5% FBS (optionally
supplemented with Zeocin or 50 mg/ml hygromycin). Follow-
ing electroporation of linearized pFRT/LacZeo plasmid, 293T
cell clones having integrated pFRT/LacZeo were selected on
Zeocin. The clones containing a single FRT site were identi-
ﬁed by Southern blot analysis. One of these clones was then
co-transfected with pOG44 and peBFP. Clones that had integ-
rated the peBFP plasmid at the FRT site via Flp recombinase-
mediatedDNA recombinationwereselectedwithhygromycin.
Southern blot analysis was used to conﬁrm that these stable
clones contained a single copy of the eBFP cDNA. The same
protocol was used to obtain 293T cells with an integrated
single copy of the rd1/eGFP* fusion construction.
In vitro analysis of gene conversion by
episomal transfection
One day before transfection, 3 · 10
5 293T cells were plated
per well for a 4 cm
2 12-well plate. For one well, 2.5 ml of Plus
Reagent (Invitrogen) were added to a mixture of 66 pmol of
ON and 0.5 mg of plasmid diluted in 62.5 ml of Opti-MEM 1.
After 15 min of incubation at room temperature, 2 ml of Lipo-
fectamine (Invitrogen) diluted in 62.5 ml of Opti-MEM 1 were
added. After 15 min of incubation at room temperature, the
mixture was added to the cells plated in 750 ml of appropriated
DMEM growth medium with 5% FBS without antibiotic.
After 3 h at 37 C, 750 ml of DMEM growth medium with
15% FBS was added. The percentage of episomal eBFP con-
version induced by different ONs (see Figure 2) was quantiﬁed
by ﬂow cytometry (see below) by dividing the percentage of
green ﬂuorescent protein (GFP)-positive cells per the percent-
age of BFP-positive cells. Each experiment was repeated at
least three times.
InvitroanalysisofgeneconversionbyONtransfectionin
stable cell lines
Optimal percentage of conversion was obtained with Lipo-
fectamine 2000 using the following protocol. One day before
transfection, 2.2 · 10
5 293T cells were plated per well for a
2c m
2 24-well plate. For one well, 2.5 ml of Lipofectamine
2000 were diluted in 62.5 ml of Opti-MEM 1 medium (Gibco
BRL). After 5 min at room temperature, Lipofectamine 2000
solutionwasmixedto132pmolofONpre-dilutedin62.5mlof
Opti-MEM 1 and incubated for 20 min at room temperature.
The mixture was added to the cells plated in 375 ml of appro-
priated growth medium with 5% FBS without antibiotic. The
resulting ON concentration was therefore of 264 nM. After 1 h
at 37 C, the medium was replaced by growth medium with 5%
FBS with hygromycin. The total number of green ﬂuorescent
cells (that were not red ﬂuorescent cells) contained in each
well was counted under a 10· objective on a DM-IRB ﬂuor-
escence microscope (Leica, Rueil Malmaison, France) with a
mobile stage. The percentage of integrated eBFP conversion
induced by different ONs (see Figure 2) was quantiﬁed by
reporting this number by the total number of cells. In cells
containing rd1-GFP construct, conversion of the rd1 stop
codon mutation lead to the expression of GFP but ﬂuorescence
levels were too low for visual counting. The percentage of
GFP-positive cells was therefore quantiﬁed by ﬂow cytometry
(as described below). Each experiment was repeated at least
three times.
Flow cytometry
Transfected 293T cells were analyzed on an EPICS Altra ﬂow
cytometer (Beckman Coulter). The 488 nm argon-ion laser
was run at 250 mW of power, and the second argon laser
was tuned to 325 nm UV and operated at 50 mW. The
green ﬂuorescence was collected after a 525–25 nm band
pass ﬁlter. For analysis, the blue emission from HO342 was
ﬁltered through a 424/44 band pass ﬁlter and a minimum of
10000 events was collected in a gate of viable cells. Analysis
of the data was performed with expo32 MultiCOMP software
(Beckman Coulter). After cell sorting, green-positive cells
were seeded in a 96-well plate and clones were expanded
on DMEM growth medium with 5% FBS and 50 mg/ml
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and 10 clones of green cells when starting from cells trans-
fected with LNA-modiﬁed ONs (n = 6 plates), whereas no
clones could be expanded from cells transfected with
phosphorothioate-modiﬁed ONs (n = 6 plates). These data
suggest that fraction cell survival is  4–10% for LNA
ON-treated cells and <0.1% (1/600) for phosphorothioate-
treated cells.
DNA sequence analyses
Genomic DNA was extracted from expanded GFP-positive
clones by isopropanol precipitation following lysis by
proteinase K digestion. Corrected eBFP cDNA was
ampliﬁed by PCR using CMV-F (cytomegalovirus-F)
(50-CGCAAATGGGCGGTAGGCGTG-30) and BGH-R (50-
TAGAAGGCACAGTCGAGG-30) primers and sequenced
by MWG-Biotech (Germany).
Analysis of gene correction in rd1 mutant mice
C3H/HeN mice homozygous for the nonsense mutation
(amino acid position 347) in the bPDE gene (Janvier,
Le Genest, France) were used. Mice were maintained in
clear plastic cages and subjected to a standard light:dark
cycle for 12 h. Experiments were conducted in accordance
with the ARVO Statement for the Use of Animals in Ophthal-
mologic and Vision Research and the institutional guidelines
regarding animal experimentation in Ophthalmic and Vision
Research. At days PN4, 6 and 8, rd1 mice received saline
iontophoresis coupled to phosphate-buffered saline (PBS) or
ONs intravitreal injections (further details are reported else-
where, C. Andrieu-Soler et al., manuscript submitted). For
tissue harvest, mice were sacriﬁced by a lethal dose of pen-
tobarbital (Ceva Sante ´ Animale, Libourne, France) injected
intraperitoneally. Eyes of PN28 untreated, PBS- or ON-treated
(six eyes for each condition) rd1 mice were enucleated,
quickly frozen in Tissue-Tek OCT-compound (Bayer Dia-
gnostics) and sectioned (10 mm). For each eye, ﬁve sections
that included optic nerve were stained with hematoxylin and
eosin. For each section, the number of nuclei in the outer
nuclear layer (ONL) was counted at 400 mm from each
edge of the optic nerve on a 400 mm length (n = 10 values
for each eye). Results were expressed as means – SD and
compared using the non-parametric Mann–Whitney test.
P < 0.05 was considered as signiﬁcant.
RESULTS
eBFP cDNA as a target for sequence-specific mutation
Blue ﬂuorescent coding sequence was originally obtained by
screening GFP mutants for altered ﬂuorescence. It was found
to depart from GFP cDNA by only two point mutations, a C to
T substitution resulting in a Y66H change in the ﬂuorophore
and a second substitution resulting in a Y145F change in a
region considered to have no role in ﬂuorescence speciﬁcity
(14). We therefore tested whether ONs of eGFP sequence
spanning codon 66 could convert eBFP cDNA into a new
GFP cDNA (coined nGFP, Figure 1) leading to the expression
of a GFP in two contexts: episomal or integrated as a single
copy transgene in cultured cells. nGFP differs from eGFP at
Figure 1. Features of assay for measuring gene editing. (A) Sequence of eBFP
and eBFP converted into a new GFP (nGFP) coding Tyr
66 and Phe
145. eGFP
sequenceisalsoindicatedtoshowthedifferencefromeBFPandnGFPatcodon
145. (B) Schematic representation of ONs tested for targeted mutagenesis.
Nomenclature:as,antisense;s,sense;ds,double-stranded;PO,phosphodiester;
PS, six phosphorothioate linkages starting from 50 and 30 ends; asterisk, phos-
phorothioate linkage; L, LNA nucleotide; LNA, LNA nucleotide at 50 and 30
end position; 1x0-LNA, LNA nucleotide at 50 end only; 0x1-LNA, LNA at 30
end only; [1x1]-LNA, LNA nucleotides at internal nucleotide positions 5 and
20; U, three 20-O-methyl uracyl RNA base starting from 50 and 30 ends;
branched-PS-eGFP, ON with specific structure consisting of double-stranded
DNA with 50 single-stranded DNA tail coupled together by a baseless deox-
yribosebranchingmonomerdescribedasB7ONin(5).430-ds-eGFP:1–430bp
of eGFP sequence. Sequences were as follows: 25-eGFPas, 50-ACTGCAC-
GCCGTAGGTCAGGGTGGT-30; 25-eGFP-s, 50-ACCACCCTGACCTACG-
GCGTGCAGT-30; 45-eGFPas,50-CGGCTGAAGCACTGCACGCCGTAGG-
TCAGGGTGGTCACGAGGGTG-30; 45-eGFPs, 50-CACCCTCGTGACCA-
CCCTGACCTACGGCGTGCAGTGCTTCAGCCG-30; 25-PDEas, 50-ACTT-
TCTGCTACGTAGGTTGGAAGG-30; 25-PDEs, 50-CCTTCCAACCTACG-
TAGCAGAAAGT-30.
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sion from potential contamination by eGFP cDNA (Figure 1).
Importantly, in this model, stable transmission of the targeted
genemodiﬁcation canbeexaminedbyselection andexpansion
of green ﬂuorescent cells.
As described in Figure 1, single-stranded ONs of sequence
identical to either sense or antisense strands of eGFP cDNA
were synthesized according to several structures previously
reported to direct sequence-speciﬁc gene modiﬁcation: stand-
ard phosphodiester chemistry (25-PO-eGFPs, 25-PO-eGFPas
and 45-PO-eGFPas), which was shown to be active in some
reports(15),modiﬁed with phosphorothioate linkagesbetween
the six bases starting from 50 and 30 ends (25-PS-eGFPs,
25-PS-eGFPas and 45-PS-eGFPas) (16), with 20Omethyl-
uracyl-RNA at the 3 positions from the 50 and 30 ends
(25-U-eGFPs, 25-U-eGFPas and 45-U-eGFPas) (17) or with
LNAs at the 50 and 30 ends (25-LNA-eGFPs, 25-LNA-eGFPas,
45-LNA-eGFPas). A branched ON, consisting of double-
stranded DNA with a 50 single-stranded DNA tail coupled
together by a baseless deoxyribose branching monomer, fol-
lowing upon the original design reported by Olsen et al. (5),
was also tested (branched-PS-eGFP) as well as a double-
stranded fragment, consisting in a PCR product of 430 bp
ampliﬁed from eGFP cDNA (18) (430-ds-eGFP).
Relative conversion of episomal eBFP sequence
As expectedfromprevious studies,alltheONsencoding eGFP
described in Figure 1 allowed detecting green ﬂuorescent cells
after being co-transfected with peBFP, whereas a control ON
encoding an unrelated sequence did not. We compared the
relative activities of the ONs to convert eBFP cDNA into
nGFP cDNA by measuring the percentage of green ﬂuorescent
cells (converted cells) relative to the number of blue ﬂuores-
cent cells (transfected cells) by ﬂow cytometry 3 days after
transfection (Figure 2 and Table 1). Based on green-cell quan-
tiﬁcation, only relative conversion rates were calculated but
this allows to compare the activity of different ONs. The most
efﬁcient were the branched-PS-eGFP and 430-ds-eGFP
vectors, which allowed obtaining green ﬂuorescence
among  74% of transfected cells. The less efﬁcient were
25-U-eGFPas and 25-PO-eGFPas, which allowed detecting
only 0.4 and 4.9% green cells, respectively. All other antisense
ONs tested showed a roughly equivalent efﬁciency ranging
between 27 and 57%. It appeared that for 25 nt long ONs, the
phosphorothioate and LNA modiﬁcations tested provided a
7-fold improvement over standard phosphodiester chemistry.
In contrast, for 45 nt long ONs, the chemical modiﬁcations
tested did not signiﬁcantly improve conversion efﬁciency. In
addition, short 25 nt ONs were superior to their longer 45 nt
counterparts. We also observed that, for a given chemistry,
both sense and antisense ONs mediated gene modiﬁcation;
however, as frequently reported in other models (3), a higher
efﬁciency was observed with the antisense ONs.
Figure2.ConversionofepisomaleBFPtoGFP.Representativedotplotsof293Tcells3daysafterco-transfectionwith(A)pLacZand45-PS-eGFPasON,(B)peBFP
and25-PS-PDEasONand(C)peBFPand45-PS-eGFPasONasdetailedinMaterialsandMethods.ThecontrolON,25-PS-PDEas,wasofsequencecomplementary
tobPDE.Thecontrolplasmid,pLacZ,wasanexpressionvectorforb-galactosidase.Bluefluorescentonlycellsareintheupperleftquadrant(UL)andgreenandblue
fluorescent cells, corresponding to converted cells, in the upper right (UR).
Table 1. Relative percentage of episomal eBFP conversion
ON Percentage of episomal
eBFP conversion – SD
25-LNA-scr 0.06 – 0.05
25-U-eGFPas 0.4 – 0.1
25-LNA-eGFPs 1.3 – 0.4
25-PO-eGFPas 5 – 0.7
25-PS-eGFPs 14 – 2
45-PS-eGFPas 27 – 2
45-PO-eGFPas 29 – 4
25-PS-eGFPas 36 – 8
25-LNA-eGFPas 37 – 3
45-U-eGFPas 47 – 6
45-LNA-eGFPas 57 – 2
430-ds-eGFP 74 – 7
Branched-PS-eGFP 74 – 5
EpisomaleBFPconversionfrequencywascalculatedasthenumberofgreenand
bluefluorescentcells(UR)dividedbythenumberofbluefluorescentcells(UL
plusUR),whichweredeterminedbyflowcytometryat3daysaftertransfection
in 293T cells of the indicated ONs. Transfection experiments were repeated
three times.
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The same set of ONs was next tested for their ability to convert
integrated eBFP cDNA into nGFP cDNA in 293T cells. For
this purpose, we created cells containing a unique copy of
eBFP, as demonstrated by Southern blot analysis (data not
shown), by the application of Flp recombinase methodology
(13). Brieﬂy, peBFP, containing an FRT site, was
co-transfected with a Flp recombinase expression vector
into 293T-FRT cells, containing a single copy FRT-target
site, and a cell clone containing appropriate single copy integ-
ration of eBFP at the FRT site was selected. In the resulting
293T-eBFP cell line, the number of green cells counted after
transfection of ONs is therefore expected to directly reﬂect the
number of target gene copies speciﬁcally mutated.
As shown in Figure 3, when 293T-eBFP cells were trans-
fected with a control ON of sequence unrelated to GFP, no
green ﬂuorescent cell was detected 3 days after transfection. In
contrast, green ﬂuorescent cells could be observed following
transfection with the 25-LNA-eGFPas ON. Table 2 shows the
rates of conversion obtained with the different ONs tested. The
branched-PS-eGFP, 25-PS-eGFPas and 25-LNA-eGFPas ONs
were the most efﬁcient ONs with efﬁciencies between 0.4 and
2‰. The less efﬁcient ONs were 25-PO-eGFPas and 25-U-
eGFPas, as in assays of episomal targets, together with,
surprising, 430-ds-eGFP, which had proven to be the most
efﬁcient on episomal targets. Other ONs tested showed efﬁ-
ciencies ranging between 0.13 and 0.2‰. It appeared that for
25 nt long ONs, similar to the results obtained on episomal
targets, the phosphorothioate and LNA modiﬁcations tested
provided a strong improvement over standard phosphodiester
chemistry (30- and 60-fold, respectively). In contrast, for
45 nt long ONs, the chemical modiﬁcations tested did not
appear to signiﬁcantly improve efﬁciency. Once more, short
25 nt ONs were superior to their longer 45 nt counterparts.
Concerning ON length, we found in independent experiments
that the short 25 nt ONs with phosphorothioate and LNA
modiﬁcations were also superior to a 60 nt long ON end-
capped with six phosphorothioate linkages (data not
shown). For a given chemistry, both sense and antisense ONs
were active; however, as observed for episomal targets, a
higher efﬁciency of gene modiﬁcation was observed with
the antisense ONs (15- and 30-fold higher for LNA and PS
chemistries, respectively).
DNA sequence analysis of chromosomal eBFP cDNA
converted to a GFP cDNA
To demonstrate that the green ﬂuorescence observed resulted
from conversion of eBFP to GFP coding sequence, we ana-
lyzed DNA sequence of the transgene. Single 293T-eBFP cells
emitting green ﬂuorescence after transfection by 25-LNA-
eGFPas ON were isolated by ﬂow cytometry and expanded.
Conﬁrmation of the conversion of eBFP to GFP conversion
came from DNA sequence analysis of ampliﬁed genomic
DNA. The analysis of four clones derived from single
293T-eBFP cells emitting green ﬂuorescence demonstrated
the speciﬁc modiﬁcation of the targeted base after transfection
with 25-LNA-eGFPas ON (Figure 4). No other difference
from eBFP sequence was found in the entire coding sequence
analyzed. In particular, codon TTC
145 speciﬁc to eBFP in the
region having no role in ﬂuorescence speciﬁcity (14) was still
present. This control ﬁnding excluded the possibility of any
cross-contamination by eGFP cDNA during the course of our
experiments.
In contrast, we were unable to expand colonies of green
ﬂuorescent cells from 293T-eBFP cultures transfected with
Figure 3. Chromosomal eBFP conversion after transfection of 293T-eBFP
cells with control or 25-LNA-eGFPas ONs. GFP expression was detected
by fluorescence microscopy of 293T-eBFP cells 3 days after transfection with
control (A) or 25-LNA-eGFPas ONs (C). Brightfield microscopy of 293T-
eBFP cells transfected with control (B) or 25-LNA-eGFPas ONs (D). The
control ON used was 25-LNA-PDEas of sequence complementary to photo-
receptor cGMP-phosphodiesterase. BFP expression could be detected
by western blot of 293T-eBFP cells but not by standard fluorescence micro-
scopy due to its low fluorescence yield and strong photobleaching compared
with GFP (14).
Table 2. Rates of chromosomal eBFP conversion in 293T-eBFP cells
ON Rate of chromosomal eBFP
conversion – SD (·10
 3)
25-LNAscr 0.007 – 0.003
25-U-eGFPas 0.02 – 0.01
430-ds-eGFP 0.04 – 0.01
25-PO-eGFPas 0.05 – 0.04
25-PS-eGFPs 0.06 – 0.005
25-LNA-eGFPs 0.13 – 0.06
45-U-eGFPas 0.16 – 0.04
45-LNA-eGFPas 0.17 – 0.03
45-PS-eGFPas 0.2 – 0.05
45-PO-eGFPas 0.2 – 0.08
Branched-PS-eGFP 0.4 – 0.08
25-PS-eGFPas 1.7 – 0.2
25-LNA-eGFPas 2 – 0.3
sequence.
RatesofchromosomaleBFPconversionwerecalculatedasthenumberofgreen
fluorescent cells detected by fluorescence microscopy 3 days after transfection
of293T-eBFPcellswiththeindicatedONsdividedbythetotalnumberofcells.
Transfectionexperimentswererepeatedatleastthreetimes.ThecontrolON,25-
LNA-scr, was of identical chemistry as 25-LNA-eGFPas but with scrambled
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ONs showing the highest efﬁciency of integrated transgene
conversion at 3days. Followingcell sorting, we also attempted
to grow cultures of pools of green ﬂuorescent cells in order to
avoid the stress due to growth of isolated cells, and we
observed that the ratio of green ﬂuorescent cells steadily
decreased over passages in culture, suggesting that the
growth of green ﬂuorescent cells was severely impaired by
25-PS-eGFPas and the branched-PS-eGFP ONs and therefore
precluded stable transmission of the gene modiﬁcation.
Conversion of chromosomal eBFP sequence by ONs
with flanking LNAs
Since 25-LNA-eGFPas proved to be one of the most efﬁcient
ONs tested in 293T cells and allowed to isolate and expand
clones of cells containing the desired sequence modiﬁcation,
LNA chemistry was further investigated.
First, dose–response studies were performed. A clear dose–
response was obtained when transfecting gradually higher
doses of 25-LNA-eGFPas ON into 293T-eBFP cells
(Figure 5A). We also examined whether repeating transfec-
tions could increase the percentage of conversion. As can be
observed in Figure 5B, one, two and three transfections every
24 h led to a progressive increase in the number of converted
cells detected.
We next tested ONs of different content in LNA nucleotides
on integrated (Table 3) eBFP target. 25-LNA-eGFPas and
25-1x0LNA-eGFPas (containing one LNA at the 50 end posi-
tion and no LNA at 30 end position) were the most efﬁcient
ONs. The 25-0x1LNA-eGFPas ON (containing no LNA at the
50 end position and one LNA at 30 end position) and the control
25-LNA-eGFP-scr ON were virtually inactive on integrated
targets, suggesting that the presence of an LNA at the 50 end
position is essential to allow detectable sequence-speciﬁc
modiﬁcation. In addition, 25-2x2LNA-eGFPas and 25-
[1x1]LNA-eGFPas ONs resulted in a slightly lower efﬁciency
than 25-LNA-eGFPas, suggesting that increasing the number
ofLNAsorinsertingLNAsatinternalrather ﬂanking positions
does not signiﬁcantly improve conversion efﬁciency. Increas-
ing the number of LNAs had previously been shown to reduce
gene editing in yeast (11).
Correction of chromosomal rd1 mutation by ONs
with flanking LNAs
We next chose to compare the ability of phosphorothioate and
LNA-modiﬁed ONs to correct a second unrelated sequence,
the rd1 stop mutation in the photoreceptor bPDE that is
responsible for retinal degeneration in the mouse rd1 mutant
(12). A fragment of the bPDE cDNA containing the rd1 stop
mutation was fused upstream of eGFP cDNA to produce a
chimeric rd1-eGFP* sequence target for correction by ONs.
Stable integration of the rd1-eGFP* sequence was performed
byFlprecombinase methodologyintothe same293T-FRTcell
Figure 4. DNA sequence analysis of converted clones. Sequence of chromo-
somal eBFP target in GFP-positive clones of 293T-eBFP cells treated with 25-
LNA-eGFPas.ThecodingsequencewasamplifiedbyPCRfromgenomicDNA
and directly sequenced, which confirmed that the eBFP sequence had been
convertedtonGFP.Theasteriskindicatesthepositionofthemodifiedbase.The
sequences shown, coding respectively Tyr
66 and Phe
145, were from the same
chromatogram.
Figure 5. Dose-dependent conversion of chromosomal eBFP by 25-LNA-
eGFPas ON. (A) Rates of GFP-positive cells in 293T-eBFP cells at 3 days
after transfection with indicated doses of 25-LNA-eGFPas ON. The amount of
DNA in the transfection mixture was kept constant by the addition of a control
LNAON ofunrelatedsequence.(B) Ratesof GFP-positivecells in 293T-eBFP
cells transfected 1, 2 or 3 times with 25-LNA-eGFPas ON (determined 3 days
after the last transfection). Results are expressed as means – SD, represented
as vertical bars, corresponding to triplicates from a single transfection
experiment.
Table3.RatesofchromosomaleBFPconversionusingdifferenttypesofLNA-
modified ONs in 293T-eBFP cells
ON Rate of chromosomal eBFP
conversion – SD (·10
 3)
25-LNA-scr 0.007 – 0.003
25-0x1LNA-eGFPas 0.05 – 0.03
25-[1x1]LNA-eGFPas 0.1 – 0.03
25-2x2LNA-eGFPas 0.7 – 0.2
25-LNA-eGFPas 2.2 – 0.3
25-1x0LNA-eGFPas 2.5 – 0.08
RatesofchromosomaleBFPconversionwerecalculatedasthenumberofgreen
fluorescent cells detected by fluorescence microscopy 3 days after transfection
of293T-eBFPcellswiththeindicatedONsdividedbythetotalnumberofcells.
Transfectionexperimentswererepeatedthreetimes.ThecontrolON,25-LNA-
scr, was of identical chemistry as 25-LNA-eGFPas but with scrambled
sequence.
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integrated at the same genomic site than the eBFP cDNA
previously studied.
In this model, correction of the rd1 mutation will result in
the appearance of eGFP ﬂuorescence. Phosphorothioate and
LNA-modiﬁed ONs were designed to correct the rd1 mutation
to wild-type bPDE. For each chemistry, sense (25-LNA-PDEs
and 25-PS-PDEs) or antisense (25-LNA-PDEas and 25-PS-
PDEas) ONs were used to target the transcribed or
non-transcribed DNA strand, respectively. When 293T-rd1-
eGFP* cells were transfected with control ON of unrelated
sequence, no GFP-positive cells were detected at 3 days after
transfection. In contrast, GFP-positive cells were observed
following transfection with 25-LNA-PDEas ON (data not
shown). Rates of gene correction by the different ONs were
measured by ﬂow cytometry and results are given in Table 4.
Phosphorothioate ONs exhibited slightly higher rd1 correction
rates than LNA ONs of the same sequence. Interestingly, even
thoughthe rd1-eGFP* target was integrated in 293T-FRT cells
at the same genomic site than the eBFP cDNA, the antisense
and sense ONs mediated gene correction at roughly identical
levels (antisense being only 1.2- and 1.4-fold more efﬁcient
than sense sequence for PS and LNA-modiﬁcations, respect-
ively). ONs with partial LNA modiﬁcation were also tested.
LNA modiﬁcation of either 50 or 30 end was sufﬁcient for gene
editing activity; however, LNA modiﬁcation at the 50 end
resulted in higher activity than at the 30 end.
Furthermore, as in studies of the eBFP target, clones were
expanded from individual green-positive cells isolated follow-
ing transfectionwith 25-LNA-PDEas,and genecorrection was
demonstrated by sequence analysis (Figure 6). In contrast, no
clones could be expanded from 293T-rd1-eGFP* cells trans-
fected with 25-PS-PDEas ON.
Improved photoreceptor cell survival in rd1 mice
treated with specific ONs with flanking LNAs
Because the rd1 mutation could be corrected by single-
stranded ONs with ﬂanking LNAs when integrated in the
genomic DNA of 293T cells, we investigated whether this
mutation could also be targeted in vivo in rd1 mice. Using
a technique that we developed for ON transfer into mouse
retina, we were recently able to detect a modest improvement
of photoreceptor survival in rd1 mice following transfer of
25-PS-PDEs ON, which was correlated with a low-level of
genecorrection(C.Andrieu-Soleretal.,manuscriptsubmitted).
Therefore, LNA and phosphorothioate-modiﬁed ONs were
transfected in retina of rd1 mice at postnatal days 4, 6 and 8.
We then examined photoreceptor cells in the ONL on eye
sections at PN28, a late degenerative stage in rd1 mice (19).
While a single row of cells was observed at PN28 in the
ONL of untreated rd1 retina (Figure 7A), numerous areas
Table 4. Rates of chromosomal rd1-eGFP* correction to bPDE-eGFP*
ON Rate of chromosomal
rd1/eGFP* correction –
SD (·10
 3)
25-1x0LNA-PDEas 3 – 0.6
25-LNA-PDEs 5 – 3
25-0x1LNA-PDEas 6 – 2
25-LNA-PDEas 7 – 4
25-PS-PDEs 13 – 6
25-PS-PDEas 16 – 5
repeated three times.
Rates of chromosomal rd1-eGFP* correction to bPDE-eGFP* were calculated
as the number of green fluorescent cells divided by the total number of cells,
which were determined by flow cytometry at 3 days after transfection of the
indicatedbPDEONsin293T-rd1-eGFP*cells.Transfectionexperimentswere
Figure 7. Eye sections of control and treated rd1 mice at PN28 and photo-
receptor cell numbers in the outer nuclear layer (ONL). Hematoxylin–eosin
stained sections of eyes of (A) untreated, (B) PBS-treated, (C) 25-PS-PDEas
ON-treated and (D) 25-LNA-PDEas ON-treated rd1 mice. A and B are repre-
sentativeoftheentireONLofthecorrespondingretinas,whereas(CandD)are
selected are as showing markedly increased cell numbers in the ONL of
ON-treated rd1 mice. Scale bars: 100 mm. (E) Counting of cells in the ONL
showed a modest but significant overall increase of cells in 25-PS-PDEas or
25-LNA-PDEas ON-treated compared to PBS-treated eyes (P < 0.0001) or
untreatedeyes(P < 0.0001)(asterisk).Resultswereexpressedasmeans – SD,
SD, represented as vertical bars, and compared using the non-parametric
Mann–Whitney test.
Figure 6. DNA sequence analyses of corrected clones. (A) rd1 and wt-bPDE
sequences. (B) Sequence of chromosomal rd1-eGFP* target in a GFP-positive
clone of 293T-rd1-eGFP* cells treated 25-LNA-PDEas. The coding sequence
was amplified by PCR from genomic DNA and directly sequenced, which
confirmedthattherd1sequencehadbeencorrectedintowt-bPDE.Theasterisk
indicates the position of the modified base.
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ONL of mice treated with 25-LNA-PDEas and 25-PS-PDEas
ONs (examples are shown in Figure 7C and 7D). Areas of
ONL showing no improvement of photoreceptor survival may
correspond to lower levels of ON transfection. In control
PBS-treated eyes, a thickening of ONL could be observed
which was small but present over the entire retina
(Figure 7B), a phenomenon which is consistently observed
upon PBS injection (20,21). In order to quantitate the effect
of ON transfection on photoreceptor survival, ONL cell num-
bers were counted in retinas from treated and untreated rd1
mice. In 25-PS-PDEas ON- and 25-LNA-PDEas ON-treated
retinas, therewas amodestbutsigniﬁcant increase inONL cell
numbers when compared with PBS-treated retinas or to the
untreated retinas from rd1 mice (Figure 7D). Results of a
preliminary screen had previously suggested that 25-PDEas
ON was inactive; the difference with the present study could
be due to synthesis or puriﬁcation defects in the previous
ON batches used. As a comparison, ONL cell numbers meas-
ured here in rd1 retinas treated with 25-PS-PDEas and
25-LNA-PDEas ONs were roughly equivalent to those
obtained previously with 25-PDEs ON (C. Andrieu-Soler
et al., manuscript submitted). These results suggest that ONs
with ﬂanking LNAs could stimulate sequence-speciﬁc modi-
ﬁcation in vivo. However, in contrast to the results obtained
in cultured cells, there was no beneﬁt of LNA over phosphoro-
thioate modiﬁcations in this in vivo assay, and the number of
photoreceptor cells remained insufﬁcient to obtain clinical
improvement.
DISCUSSION
Testing activity of ONs on single copy model
target genes
In order to measure gene editing at the single cell level, we
have used assays depending on detecting GFP following tar-
geted modiﬁcation of GFP mutant cDNAs consisting either of
eBFP or a fusion between rd1-bPDE and GFP cDNAs.
Because we applied Flp recombinase methodology, we
could easily obtain cell lines containing the transgenes
integrated as transcriptionally active single copies. As a con-
sequence, GFP-ﬂuorescence indicates the successfulmodiﬁca-
tion of the target gene and the number of GFP-positive cells
provides a measure of target gene modiﬁcation. Indeed, we
could rigorously validate the assay by directly showing that in
GFP-positive cells, the desired gene modiﬁcation had been
successfully introduced and stably propagated after transfec-
tion with sequence-speciﬁc ONs with ﬂanking LNAs. An asset
of our experimental approach is that further use of Flp recom-
binase methodology will allow introducing different model
gene targets at identical genomic sites and it should therefore
be invaluable to analyze the importance of the target DNA
sequence in gene editing. It should also facilitate the charac-
terization of complex ONs, such as RNA/DNA ONs, whose
gene editing efﬁciency can vary from one synthesis to another
(3,22,23). The strategy we have used to test correction of the
rd1 mutation, relying on detecting correction of an inactive
GFP fusion cDNA, could be easily applied to test the possib-
ility of correcting other stop codons involved in human or
animal diseases.
Strand-bias in ON-mediated mutagenesis is
dependent on target sequence
Targeted gene modiﬁcation by ONs takes place in two steps:
pairing to the target, which likely involves protein complexes
that usually take part in homologous recombination, and gene
modiﬁcation per se, which may involve mismatch repair or
other mechanisms (3). For the eBFP sequence, we have found
here that targeting the transcribed strand was much more efﬁ-
cient than targeting the non-transcribed strand (15- to 30-fold),
as reported in most studies (3). In contrast, for the rd1-eGFP*
sequence, there was no signiﬁcant difference. The two targets
tested, eBFP and rd1-eGFP*, were integrated at the same
genomic site of 293T-FRT cells and transcribed from the
same CMV promoter. Therefore, our results indicate that
the target sequence may by itself determine a strand-bias in
targeting efﬁciency, perhaps as a result of different abilities to
reach and pair to their target. A similar conclusion was
recently proposed following studies of an episomal target
(24). Such a conclusion does not exclude; however, that
genomic context (for example, determining orientation and
timing of replication) or the promoter of the target sequence
play an additional role in strand-bias. Until the molecular
mechanisms of gene editing by ONs are better understood,
it therefore remains important to test the activity of the two
complementary sequences in order to achieve the best efﬁci-
ency of gene editing.
Properties of the ON vectors
Using our assays of episomal and integrated eBFP targets, we
have compared the activity of several types of single-stranded
ONs as well as a branched ON and a double-stranded frag-
ment. It appeared that short single-stranded ONs with ﬂanking
LNAs were efﬁcient vectors, allowing gene editing of 0.2%
integrated eBFP target sequences. Importantly, similar efﬁ-
ciencies were observed for the second target tested here,
the rd1 stop mutation, as well as for a third unrelated sequence
(C.Andrieu-Soleretal.,manuscriptinpreparation),suggesting
that short ONs with ﬂanking LNAs constitute a simple and
robust ON design for gene editing.
When comparing single-stranded vectors targeting the
eBFP sequence, several observations could be made. First,
we found that 25 nt ONs end-capped with single LNAs or
with six phosphorothioate linkages were 30- to 60-fold more
efﬁcient than their non-modiﬁed counterparts, most likely due
to increased resistance to nucleases and as a consequence a
higher concentration of effective ON reaching the nucleus
after transfection. Second, we also found that 25 nt ONs
end-capped with single LNAs or with six phosphorothioate
linkages were consistently superior to their longer counter-
parts. Shorter ONs may mediate more efﬁcient gene editing
per se, for instance as a result of higher afﬁnity to proteins
facilitating recognition or invasion of the target double-
stranded sequence. Longer ONs may also be more prone to
binding to non-speciﬁc sites, thereby diluting effective ON
concentration at the targeted sequence. Third, we found that
chemically modiﬁed ONs of 45 nt were not superior to the ON
of standard chemistry. This observation was unexpected and
may perhaps be explained by the ability of the 45 nt sequence
to adopt structures conferring resistance to nucleases. In any
case, we must be cautious in interpreting differences between
3740 Nucleic Acids Research, 2005, Vol. 33, No. 12ON activities. Many steps are necessary to achieve gene
editing: transfection, nucleocytoplasmic transport, binding
to molecular machines responsible for DNA editing, annealing
to target DNA, degradation by nucleases..., all of which may
be differentially affected by ON chemistry and sequence and
impact on ﬁnal ON activity.
Surprisingly, the 430-ds-eGFP exhibited limited activity
on integrated targets even though it was relatively efﬁcient
on episomal eBFP cDNA. We tested extensive transfection
conditions but no increase in conversion of chromosomal
eBFP could be observed (data not shown). Differences in
transfection conditions may be involved but are unlikely to
entirely explain the very low activity of 430-ds-eGFP on
integrated targets. In our model, the sequence homologous
to 430-ds-eGFP starts immediately downstream of the
CMV transcription initiation site. In consequence, association
of 430-ds-eGFP to its homologous sequence or recruitment of
the recombination machinery may be limited by the transcrip-
tion initiation complex. Considering the high efﬁciency of
small homologous fragments reported in other studies (18),
our ﬁnding suggests that this method is extremely target-
dependent. It nevertheless deserves further investigation,
because it may allow performing more extensive mutations
than with shorter ONs.
We have also found that a branched ON was roughly equi-
valent to the best single-stranded vectors on both episomal and
chromosomal targets. This is the second example of gene
targeting with branched ONs, which were originally designed
by Olsen et al. (5), and it therefore proves to be an efﬁcient
vector. The branched ON structure is reminiscent of results
obtained by Parekh-Olmedo et al. (11), who showed that in
yeast, a hybrid between a long ON and a shorter complement-
ary ON could exhibit higher activity than either ON taken
alone. However, in our hands, such hybrids did not signiﬁc-
antly change gene editing levels, whether annealing of
ONs was performed prior to transfection or not (data not
shown).
Stable transmission of targeted gene modification by
ONs with flanking LNAs
LNAs are proving to be versatile reagents in many aspects of
gene control and manipulation (10). Insertion of LNAs into an
ON was originally designed toincreasebindingafﬁnitytoward
complementary DNA and RNA. LNAs are therefore important
tools in diagnostic and analytical applications involving nuc-
leic acid hybridization. Additional important beneﬁts were
found in LNAs, including resistance to nucleases (25,26).
In our study, an ON with a single LNA at its 50 end only
was as efﬁcient as an ON ﬂanked by LNA at both ends on
theeBFPsequencetargetandanONwithasingleLNAatits30
end only was as efﬁcient as an ON ﬂanked by LNA at both
ends on the second rd1-eGFP sequence target. Therefore, a
single protection may be sufﬁcient but no general rule can be
made: the differences observed between ONs with a single
LNA at either 50 or 30 end are gene dependent. LNA modi-
ﬁcation at both ON ends therefore appears to be the optimal
chemistry to use for gene editing. A second important feature
of ONs incorporating LNAs is their low toxicity in vivo
(25,26). The latter property likely explains why LNA-
modiﬁed ONs were superior to the branched and
PS-modiﬁed ONs in making it possible to isolate clones of
cells bearing the desired sequence-speciﬁc modiﬁcation.
Branched ONs have been previously shown to be cytotoxic
(5), apoptosis being triggered in corrected cells. Cytotoxicity
is also a well-known caveat of phosphorothioate ONs that
likely explains why growth of corrected cells appeared
severely impaired. Other studies of gene editing by
phosphorothioate-modiﬁed ONs have either described normal
growth of corrected cells (16) or impaired cell cycle progres-
sion (27). Cytotoxicity of phosphorothioate-modiﬁed ONs is
known to be sequence-dependent (28) and this could explain
such variability in the growth of corrected cells. Other experi-
mental differences may also be involved, such as cell lines and
ON transfection reagents used. Variable success has similarly
been reported for RNA/DNA ONs, which either did (29) or did
not (30) allow growth and isolation of corrected cells. Pos-
sibly, further studies of such ONs may allow reducing their
cytotoxicity without compromising their ability to mediate
gene modiﬁcation. However, in contrast, the use of 25 nt
ONs with ﬂanking LNAs appears to provide a straightforward
and robust design for obtaining cell lines containing stable
transmission of the desired gene modiﬁcation. In addition
to the two targets described here, we have recently obtained
293T cell lines with modiﬁcation of several other model
sequences, further validating the power of ONs with ﬂanking
LNAs. The next step will hence consist in demonstrating tar-
geting of endogenous genes. The mutagenesis rates measured
here, in the range of 0.1–0.5%, appear too low to envisage
direct isolation of modiﬁed cells. Progressive isolation from
pools of treated cells by PCR (15) or the use of a selection
strategy, as suggested by Yoon and co-workers (31), will
therefore be necessary to obtain cells with targeted mutations
in endogenous genes. Mutagenesis rates may also be increased
as a result of better understanding of the mechanisms of gene
editing directed by ONs (32) or by the simultaneous use of
triplex-forming ONs (6).
Finally, we compared the activity of LNA- and
phosphorothioate-containing ONs in the rd1 mouse model.
Following transfer of ONs into the retina of rd1 mouse mutant,
an ON with ﬂanking LNAs led to a modest but signiﬁcant
increase in photoreceptor survival, which was slightly lower
than that obtained with phosphorothioate ONs. This result is
consistent with the ﬁnding that the ON with ﬂanking LNAs
was less active on the single copy rd1-eGFP* transgene than
the phosphorothioate ON at 3 days after transfection. Given
that photoreceptor cells stop dividing after postnatal day 6, i.e.
during the period when ON treatments were performed in rd1
mice, it may not be so surprising that the differences observed
on growth of cultured cells in vitro do not translate into a
detectable advantage when treating rd1 photoreceptor cells.
One may expect to observe an advantage of LNA- over
phosphorothioate-modiﬁed ONs in treatment of diseases
involving proliferating cells or when correction rates achieved
lead to therapeutic beneﬁt and differences in toxicity between
the two chemistries then become relevant. The comparison we
have performed of targeted mutagenesis directed by LNA- or
phosphorothioate-modiﬁed ONs on different targets illustrates
the need to carefully tailor ON design to the speciﬁc gene
target and experimental purpose. Our ﬁnding that ONs with
ﬂanking LNAs allow to reliably isolate cell lines containing
the desired genemodiﬁcations mayhelp infurther applications
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and gene therapy.
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